Paper575446
Epidemic Rift Valley fever in Egypt: observations of the spectrum of human illness.
Laughlin LW and 4 others. Trans R Soc Trop Med Hyg, 1979. Cited by 241 papers, by iCite.
Cite this record
ConductScience Library. Epidemic Rift Valley fever in Egypt: observations of the spectrum of human illness. Papers, record 575446. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/575446
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Rift Valley Fever | Major topic |
| Adolescent | |
| Adult | |
| Animals | |
| Child | |
| Child, Preschool | |
| Egypt | |
| Eye Diseases | |
| Female | |
| Hemorrhage | |
| Humans | |
| Jaundice | |
| Male | |
| Meningoencephalitis | |
| Middle Aged |
Source PubMed
Cited by128
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 241 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42623406 | Viral and host determinants of arboviral disease severity in African populations: A systematic review with meta-analysis. | PLoS Negl Trop Dis | 2026 | https://conductscience.org/library/papers/42623406 | PubMed |
| 42607044 | Opportunities and challenges for countermeasures against Rift Valley fever virus: A quintessential One Health pathogen. | PLoS Negl Trop Dis | 2026 | https://conductscience.org/library/papers/42607044 | PubMed |
| 42043234 | A Newly Established ELISA for the Surveillance of Rift Valley Fever in Dromedary Camels and Their Owners, Kenya 2018. | Viruses | 2026 | https://conductscience.org/library/papers/42043234 | PubMed |
| 41961907 | Epidemiological and molecular characterization of Rift Valley fever outbreak in livestock in Burundi, May - November 2022. | PLoS Negl Trop Dis | 2026 | https://conductscience.org/library/papers/41961907 | PubMed |
| 41902294 | In Vitro and In Vivo Models for Drug Development Against Two Hemorrhagic Hareavirales: Rift Valley Fever and Crimean Congo Hemorrhagic Fever Viruses. | Viruses | 2026 | https://conductscience.org/library/papers/41902294 | PubMed |
| 41568981 | Rift Valley fever virus activates multiple cell death pathways in neurons. | J Virol | 2026 | https://conductscience.org/library/papers/41568981 | PubMed |
| 40715124 | Maternal vaccination with live-attenuated Rift Valley fever virus protects offspring via immune transfer. | NPJ Vaccines | 2025 | https://conductscience.org/library/papers/40715124 | PubMed |
| 40703920 | Research trends in Rift Valley fever virus: a bibliometric analysis from 1936 to 2024. | Front Vet Sci | 2025 | https://conductscience.org/library/papers/40703920 | PubMed |
| 40630111 | The public health threat of emerging phenuiviruses. | One Health | 2025 | https://conductscience.org/library/papers/40630111 | PubMed |
| 39928032 | Rift Valley Fever Virus Infectivity in Milk Stored at a Wide Range of Temperatures. | J Infect Dis | 2025 | https://conductscience.org/library/papers/39928032 | PubMed |
| 39452727 | A Review of Nonhuman Primate Models of Rift Valley Fever Virus Infection: Progress, Challenge Strains, and Future Directions. | Pathogens | 2024 | https://conductscience.org/library/papers/39452727 | PubMed |
| 39345143 | Rift Valley fever virus is able to cross the human blood-brain barrier in vitro by direct infection with no deleterious effects. | J Virol | 2024 | https://conductscience.org/library/papers/39345143 | PubMed |
| 39159263 | The Rift Valley fever (RVF) vaccine candidate 40Fp8 shows an extreme attenuation in IFNARKO mice following intranasal inoculation. | PLoS Negl Trop Dis | 2024 | https://conductscience.org/library/papers/39159263 | PubMed |
| 39088277 | Potent neutralizing human monoclonal antibodies protect from Rift Valley fever encephalitis. | JCI Insight | 2024 | https://conductscience.org/library/papers/39088277 | PubMed |
| 39057809 | Monoclonal Antibodies for Rift Valley Fever Virus Nucleocapsid: Application in IgG/IgM ELISA for Sero-Diagnosis. | Pathogens | 2024 | https://conductscience.org/library/papers/39057809 | PubMed |
| 39039428 | Laboratory Animal Models for Rift Valley Fever Virus Disease. | Methods Mol Biol | 2024 | https://conductscience.org/library/papers/39039428 | PubMed |
| 39039413 | Making Rift Valley Fever Viral Particles Fluorescent. | Methods Mol Biol | 2024 | https://conductscience.org/library/papers/39039413 | PubMed |
| 39039406 | Analysis of Negative-Strand RNA Viruses by RT-qPCR: Rift Valley Fever Virus and Toscana Virus. | Methods Mol Biol | 2024 | https://conductscience.org/library/papers/39039406 | PubMed |
| 38935789 | The lipopeptide Pam3CSK4 inhibits Rift Valley fever virus infection and protects from encephalitis. | PLoS Pathog | 2024 | https://conductscience.org/library/papers/38935789 | PubMed |
| 38635867 | Rift Valley Fever Virus Encephalitis: Viral and Host Determinants of Pathogenesis. | Annu Rev Virol | 2024 | https://conductscience.org/library/papers/38635867 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/575446
GET https://conductscience.org/api/papers/v1/575446/cited_by?page=2